コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 can result in diagnosis with an ASD or other neuropsychiatric disorder.
2 e at multiple biological levels in a complex neuropsychiatric disorder.
3 ne encoding CaMKIIalpha linked to a specific neuropsychiatric disorder.
4 jectory to functional deficits in a model of neuropsychiatric disorder.
5 suggested that defective microglia cause the neuropsychiatric disorder.
6 Bipolar affective disorder is a common neuropsychiatric disorder.
7 e pathogenesis and treatment of nearly every neuropsychiatric disorder.
8 ctors contributing to neurodevelopmental and neuropsychiatric disorders.
9 atory variants across neurodevelopmental and neuropsychiatric disorders.
10 rain as well as its potential involvement in neuropsychiatric disorders.
11 ial survival mechanism often dysregulated in neuropsychiatric disorders.
12 ighest known genetic risks for developmental neuropsychiatric disorders.
13 upted as part of the pathophysiology of many neuropsychiatric disorders.
14 brain and behavioral phenotypes relevant to neuropsychiatric disorders.
15 ating their impact on neurodevelopmental and neuropsychiatric disorders.
16 naling-associated genes, have been linked to neuropsychiatric disorders.
17 rol processes and is dysregulated in several neuropsychiatric disorders.
18 f neurodevelopmental, neurodegenerative, and neuropsychiatric disorders.
19 expression may be differentially altered in neuropsychiatric disorders.
20 binoid signaling are associated with various neuropsychiatric disorders.
21 ould contribute to a range of neurologic and neuropsychiatric disorders.
22 Ca(2+) signalling to the pathophysiology of neuropsychiatric disorders.
23 de or too narrow generalization is linked to neuropsychiatric disorders.
24 terizations in the differential diagnosis of neuropsychiatric disorders.
25 terizing deficits and refining treatments in neuropsychiatric disorders.
26 the brain, and are an intriguing target for neuropsychiatric disorders.
27 implicated in the pathophysiology of several neuropsychiatric disorders.
28 nd social behavioral disturbances present in neuropsychiatric disorders.
29 may underlie pathophysiology associated with neuropsychiatric disorders.
30 ments of candidate genes in the pathology of neuropsychiatric disorders.
31 ptor is an attractive therapeutic target for neuropsychiatric disorders.
32 diagnosis of various neuropsychological and neuropsychiatric disorders.
33 it and which is vulnerable to impairments in neuropsychiatric disorders.
34 attentional symptoms that accompany several neuropsychiatric disorders.
35 aviors, and cognition as well as in numerous neuropsychiatric disorders.
36 referential degradation in aging and various neuropsychiatric disorders.
37 e pathophysiology of an increasing number of neuropsychiatric disorders.
38 ocial behavior, including its dysfunction in neuropsychiatric disorders.
39 going effort to develop novel treatments for neuropsychiatric disorders.
40 nd gender-matched control adults without any neuropsychiatric disorders.
41 thought to contribute to neurocognitive and neuropsychiatric disorders.
42 prehensive catalog of the DNMs identified in neuropsychiatric disorders.
43 , human development, infertility and risk of neuropsychiatric disorders.
44 ion of executive function is present in many neuropsychiatric disorders.
45 , and highlights novel mechanisms underlying neuropsychiatric disorders.
46 ving prevention and treatment approaches for neuropsychiatric disorders.
47 the core of disabling cognitive deficits in neuropsychiatric disorders.
48 tment in healthy subjects, is compromised in neuropsychiatric disorders.
49 iscussing potential opportunities to prevent neuropsychiatric disorders.
50 ttention, which are all severely affected in neuropsychiatric disorders.
51 , aversion, salience, cognition, and several neuropsychiatric disorders.
52 ant spine morphology is associated with many neuropsychiatric disorders.
53 aka 22q13 microdeletion) syndrome, and other neuropsychiatric disorders.
54 nsmission and are associated with a range of neuropsychiatric disorders.
55 ns in signal propagation in neurological and neuropsychiatric disorders.
56 , and the contribution of LCN dysfunction to neuropsychiatric disorders.
57 lator with known links to a wide spectrum of neuropsychiatric disorders.
58 imal behavioral choices and the emergence of neuropsychiatric disorders.
59 like family (Slitrks) as candidate genes for neuropsychiatric disorders.
60 tions for our understanding and treatment of neuropsychiatric disorders.
61 in functional surgery for movement and other neuropsychiatric disorders.
62 to attention, as well as in neurological and neuropsychiatric disorders.
63 e brain may contribute to the development of neuropsychiatric disorders.
64 t human behaviors, and is often disrupted in neuropsychiatric disorders.
65 terventions to address cognitive deficits in neuropsychiatric disorders.
66 mutations in various neurodevelopmental and neuropsychiatric disorders.
67 unication are relevant to the development of neuropsychiatric disorders.
68 nd targeted therapeutics across the range of neuropsychiatric disorders.
69 considered an etiological factor in several neuropsychiatric disorders.
70 lved in the pathophysiology of several major neuropsychiatric disorders.
71 investigate mechanisms underlying these key neuropsychiatric disorders.
72 ysiology underlying deficits associated with neuropsychiatric disorders.
73 isplay cognitive deficits, even when free of neuropsychiatric disorders.
74 ritical for elucidating brain dysfunction in neuropsychiatric disorders.
75 human genome and may contribute to risk for neuropsychiatric disorders.
76 n tyrosine phosphatase implicated in several neuropsychiatric disorders.
77 synapse architecture that are implicated in neuropsychiatric disorders.
78 on molecule of inhibitory synapses linked to neuropsychiatric disorders.
79 malities in regional CBF are present in many neuropsychiatric disorders.
80 be related to anxiety and the development of neuropsychiatric disorders.
81 normal foetal neurodevelopment that leads to neuropsychiatric disorders.
82 e as early therapeutic targets for late-life neuropsychiatric disorders.
83 an Americans, and patients with diabetes and neuropsychiatric disorders.
84 remote functional coupling in patients with neuropsychiatric disorders.
85 ty from non-communicable diseases, including neuropsychiatric disorders.
86 ncrease the risk of a broad range of complex neuropsychiatric disorders.
87 er role in cognition and its disturbances in neuropsychiatric disorders.
88 in shaping the overall phenotypes of genetic neuropsychiatric disorders.
89 n (OT) is a potential treatment for multiple neuropsychiatric disorders.
90 d objectively defining subtypes within other neuropsychiatric disorders.
91 impacted during the course of developmental neuropsychiatric disorders.
92 urons in emotional deficits portending major neuropsychiatric disorders.
93 whereby neuroligin-3 mutations contribute to neuropsychiatric disorders.
94 s, which are often observed in patients with neuropsychiatric disorders.
95 esistant epileptic seizures, and more severe neuropsychiatric disorders.
96 nificantly overlap with loci associated with neuropsychiatric disorders.
97 a vulnerable target of many neurological and neuropsychiatric disorders.
98 variants have been reported in patients with neuropsychiatric disorders.
99 l process in the trajectory of developmental neuropsychiatric disorders.
100 rment in this development is associated with neuropsychiatric disorders.
101 replicable susceptibility genes for several neuropsychiatric disorders.
102 nction in specific subtypes is implicated in neuropsychiatric disorders.
103 dissection of neural circuits implicated in neuropsychiatric disorders.
104 ations of the two can be sufficient to cause neuropsychiatric disorders.
105 o behavioural and health outcomes, including neuropsychiatric disorders.
106 approaches for the treatment of a variety of neuropsychiatric disorders.
107 d to discover unknown neuronal phenotypes of neuropsychiatric disorders.
108 ion molecules implicated in autism and other neuropsychiatric disorders.
109 te aspects of the psychopathology of several neuropsychiatric disorders.
110 ber variation (CNV) is an important cause of neuropsychiatric disorders.
111 viously implicated in neurodevelopmental and neuropsychiatric disorders.
112 ritis, inflammatory bowel diseases, and even neuropsychiatric disorders.
113 into the imbalance of brain states found in neuropsychiatric disorders.
114 functions and is critically involved in many neuropsychiatric disorders.
115 increases risk for complex traits, including neuropsychiatric disorders.
116 ion of SWI/SNF-regulated genes implicated in neuropsychiatric disorders.
117 s increased risk for a range of debilitating neuropsychiatric disorders.
118 volume and shape are found in several common neuropsychiatric disorders.
119 iscussing ways to consider sex when studying neuropsychiatric disorders.
120 of resting-state networks (RSNs) in several neuropsychiatric disorders.
121 nd a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, includi
122 f chromosome 16 region 16p11.2 are linked to neuropsychiatric disorders and are among the most preval
123 regulation of neuronal function relevant to neuropsychiatric disorders and clarify the role of Kctd1
125 s, here we posit that the connection between neuropsychiatric disorders and dysregulated DG neurogene
126 linical trials for the treatment of multiple neuropsychiatric disorders and have shown promise in pre
128 ive behaviour is associated with a number of neuropsychiatric disorders and is thought to result part
129 found in postmortem brain tissue for several neuropsychiatric disorders and may be related to symptom
132 clinical manifestations, for characterizing neuropsychiatric disorders and personalizing treatments.
134 variants is a key challenge in understanding neuropsychiatric disorders and will open an avenue in th
135 ic neurological problems including epilepsy, neuropsychiatric disorders, and dementia through unknown
136 ulsivity is an important feature of multiple neuropsychiatric disorders, and individual variation in
137 urons are implicated in cognitive functions, neuropsychiatric disorders, and pathological conditions;
138 coexpressed networks of genes implicated in neuropsychiatric disorders, and the expression of these
139 dysregulated in postmortem neuropathology of neuropsychiatric disorders, and there is strong genetic
140 ghs elucidating the developmental origins of neuropsychiatric disorders, and thus understanding patho
141 y an invertebrate organism in the context of neuropsychiatric disorders, and we discuss how we can ga
142 f human infections and neurodegenerative and neuropsychiatric disorders, animal models of BDV infecti
148 higher-order brain functions, and many human neuropsychiatric disorders are due to genetic defects af
155 ceutical industry has recently de-emphasized neuropsychiatric disorders as 'too difficult' a challeng
156 as a way to further evaluate M1R changes in neuropsychiatric disorders, as a potential stratifying b
157 Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder associated with significant im
158 mGluR5 as a potential therapeutic target in neuropsychiatric disorders associated with abnormal nove
159 rders, a concept termed pediatric autoimmune neuropsychiatric disorders associated with streptococcal
160 eved 17,104 DNMs from 3555 trios across four neuropsychiatric disorders: autism spectrum disorder, ep
161 mutation datasets of neurodevelopmental and neuropsychiatric disorders: autism spectrum disorder, ep
162 al need to reassess diagnostic boundaries of neuropsychiatric disorders before discussing ways forwar
163 mics can predict response to treatment for a neuropsychiatric disorder better than conventional clini
164 itude of delayed-onset neurodegenerative and neuropsychiatric disorders, but complete understanding o
165 understanding of the genetic architecture of neuropsychiatric disorders, but it has also led to a bro
166 al cortex (mPFC) is consistently observed in neuropsychiatric disorders, but the mechanisms involved
167 nment interactions impact the development of neuropsychiatric disorders, but the relative contributio
168 SC technology to model and potentially treat neuropsychiatric disorders by focusing on the most preva
169 rget dopamine receptors for the treatment of neuropsychiatric disorders can act in the basal ganglia
170 the behavioral symptoms in animal models of neuropsychiatric disorders can be produced or exacerbate
175 ed in obsessive compulsive disorder (OCD), a neuropsychiatric disorder characterized by the execution
178 on EE as a potential treatment in models for neuropsychiatric disorders characterized by social defic
181 nd their ligands are associated with diverse neuropsychiatric disorders, especially schizophrenia, au
182 he field of neuropsychopharmacology, as many neuropsychiatric disorders exhibit gender bias in the fr
183 smokers (mean age = 25 years; no history of neuropsychiatric disorders), following an overnight peri
184 have been found unsuitable for treatment of neuropsychiatric disorders for reasons such as inability
185 ve functions in people with neurological and neuropsychiatric disorders has been a major goal of psyc
186 -related behavior and the physiopathology of neuropsychiatric disorders has been accepted, a detailed
187 ized stimulation of the human brain to treat neuropsychiatric disorders has been in place for over 20
188 autoantibodies against neuronal receptors in neuropsychiatric disorders has fostered new conceptual a
189 Hundreds of genetic loci increasing risk for neuropsychiatric disorders have recently been identified
191 epistatic events and genetic interactions in neuropsychiatric disorders, how paradigm shifts in the p
192 othesized to be a major component of various neuropsychiatric disorders; however, the mechanisms regu
193 a family-based paradigm for modeling complex neuropsychiatric disorders in conjunction with in-depth
196 , as composite gene sets associated with six neuropsychiatric disorders in the microarray-based "Brai
197 to study a variety of neurodegenerative and neuropsychiatric disorders in vivo and to support drug-d
199 ) in the brain has been detected in numerous neuropsychiatric disorders including Alzheimer's disease
201 merged as a candidate risk gene for multiple neuropsychiatric disorders including bipolar disorder, m
202 nctional mutations in known causal genes for neuropsychiatric disorders including holoprosencephaly a
203 undergoing deep brain stimulation (DBS) for neuropsychiatric disorders including major depressive di
204 omponent of memories allowing alleviation of neuropsychiatric disorders including PTSD and drug addic
205 rgic dysregulation characterizes a number of neuropsychiatric disorders including schizophrenia and a
206 on circuitry have been implicated in several neuropsychiatric disorders, including addiction and schi
207 eptor dysfunction has been linked to several neuropsychiatric disorders, including Alzheimer's diseas
208 t causes of a broad spectrum of debilitating neuropsychiatric disorders, including anxiety, schizophr
209 d amphetamine-and plays an important role in neuropsychiatric disorders, including attention-deficit
210 y patterns between resting state networks in neuropsychiatric disorders, including Autism Spectrum Di
211 ellitus, and autoimmune disorders as well as neuropsychiatric disorders, including autism, anxiety, a
212 ess affected in a number of neurological and neuropsychiatric disorders, including fragile X syndrome
213 is characteristically disrupted in multiple neuropsychiatric disorders, including major depressive d
214 indings on the alterations in this system in neuropsychiatric disorders, including Parkinson's diseas
215 essed throughout limbic circuits affected in neuropsychiatric disorders, including prefrontal cortex
216 e decision making is associated with several neuropsychiatric disorders, including problem gambling a
217 s been associated with dopamine (DA)-related neuropsychiatric disorders, including schizophrenia, a d
218 ad to cognitive deficits comorbid with human neuropsychiatric disorders, including schizophrenia, aut
219 C spontaneous default activity is altered in neuropsychiatric disorders, including schizophrenia-a di
220 been associated with abnormal motivation in neuropsychiatric disorders, including schizophrenia.
221 a genetic risk factor for developing several neuropsychiatric disorders, including schizophrenia.
222 nd are implicated in the etiology of several neuropsychiatric disorders, including substance use diso
224 lex array of social impairments accompanying neuropsychiatric disorders involving dopaminergic dysreg
225 ic factors underlying neurodevelopmental and neuropsychiatric disorders is a major challenge given th
226 f DBS and other forms of neuromodulation for neuropsychiatric disorders is the result of the ability
227 ntific endeavour for complex behaviour-based neuropsychiatric disorders is to examine intermediate bi
228 arch methods to probe the pathophysiology of neuropsychiatric disorders is well afoot and continues t
231 ch a functional biomarker may be of value to neuropsychiatric disorders like bipolar and autism spect
232 2 receptor (D2R) activity is associated with neuropsychiatric disorders, making those receptors targe
233 rd hypersensitization is a common feature of neuropsychiatric disorders, manifesting as impulsivity f
234 stem are linked to multiple neurological and neuropsychiatric disorders, many of which present with s
235 tes how linking aberrant network dynamics to neuropsychiatric disorders may lead to new circuit-based
236 According to the depression-as-late-life-neuropsychiatric-disorder model, lower hippocampal volum
237 vocal communication are hallmarks of several neuropsychiatric disorders, most notably autism spectrum
238 stasis and pathophysiological states such as neuropsychiatric disorders, neurodegeneration, sterile i
239 , as characterized by neurodevelopmental and neuropsychiatric disorders, neuromuscular and neurodegen
240 e beneficial effects of physical exercise in neuropsychiatric disorders, neurorehabilitation, aging,
241 Schizophrenia (SCZ) is a highly heritable neuropsychiatric disorder of complex genetic etiology.
242 Mutations in MECP2 cause a broad spectrum of neuropsychiatric disorders of which Rett syndrome repres
243 It is consistently and severely affected in neuropsychiatric disorders originating during developmen
244 a promising biomarker of susceptibility for neuropsychiatric disorders, particularly because of its
245 f interference-related cognitive symptoms in neuropsychiatric disorders, particularly considering the
246 ontrol may be a biomarker of a wide range of neuropsychiatric disorders, particularly in the schizoph
247 l models can inform translational studies of neuropsychiatric disorders, partitioning of the DMN in n
250 ns so extensive that it is often affected by neuropsychiatric disorders, producing measurable atypica
251 he risk for offspring neurodevelopmental and neuropsychiatric disorders, prompting critical examinati
252 e a neurogenetic framework for understanding neuropsychiatric disorders related to reproductive hormo
254 nt role for integrins in modulating risk for neuropsychiatric disorders.SIGNIFICANCE STATEMENT The in
255 NMDAR modulators to enhance memory and treat neuropsychiatric disorders such as addiction, depression
256 of-function mutations of DAT associated with neuropsychiatric disorders such as attention deficit hyp
260 have been associated with increased risk for neuropsychiatric disorders such as major depression and
261 nd cognitive processing that are impaired in neuropsychiatric disorders such as Parkinson's disease o
262 ppetitive, and aversive behavior, as well as neuropsychiatric disorders such as Parkinson's disease,
263 White matter abnormalities are prevalent in neuropsychiatric disorders such as schizophrenia, but it
264 provide novel insights into neurological and neuropsychiatric disorders, such as autism and schizophr
265 aminobutyric acidergic interneurons in human neuropsychiatric disorders, such as autism, epilepsy, an
266 or ankyrin-G, to be a risk gene for multiple neuropsychiatric disorders, such as bipolar disorder, sc
267 in the fields of human neurodegenerative and neuropsychiatric disorders, such as Huntington's disease
268 pathy, osteoporosis, and skeletal fractures; neuropsychiatric disorders, such as impairment of cognit
269 herapeutic intervention for the treatment of neuropsychiatric disorders, such as post-traumatic stres
270 particularly strong memories that can drive neuropsychiatric disorders, such as posttraumatic stress
273 te receptor (NMDAR) encephalitis is a severe neuropsychiatric disorder that associates with prominent
275 IGNIFICANCE STATEMENT Cocaine addiction is a neuropsychiatric disorder that is detrimental to society
277 ing normal brain development, as well as the neuropsychiatric disorders that emerge in this vulnerabl
279 e major diagnostic symptoms in a spectrum of neuropsychiatric disorders that include schizophrenia, o
286 To better understand the role of CREs in neuropsychiatric disorders we applied the Assay for Tran
288 To investigate the expression of RPTN in neuropsychiatric disorders, we determined serum levels o
289 more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the cla
291 uring pregnancy have each been implicated in neuropsychiatric disorders, whether and how these presum
292 Schizophrenia is a debilitating familial neuropsychiatric disorder which affects 1% of people wor
293 common variants that increase the risk of a neuropsychiatric disorder, while there is growing eviden
294 s de la Tourette syndrome (GTS) is a complex neuropsychiatric disorder with a strong genetic influenc
297 ted.Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with symptoms including intrus
298 or pharmacological manipulation of Cav1.2 in neuropsychiatric disorders with developmental and/or str
299 of chromosome 15q13.3 manifest clinically as neuropsychiatric disorders with variable expressivity.
300 r incidence is among the most extreme of all neuropsychiatric disorders, yet the origins of the sex d
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。